Cagrilintide is a long-acting synthetic amylin analog used in laboratory models of amylin and calcitonin receptor signaling. Amylin is co-secreted with insulin from pancreatic beta cells, and engineered analogs of that peptide have become common tools for receptor pharmacology, ligand-binding, and pathway-comparison work. This overview covers Cagrilintide as a research peptide; for related metabolic tools, see the GLP-3 research compound overview and the 5-Amino-1MQ overview.
What Is Cagrilintide?
Cagrilintide is an acylated, long-acting analog of amylin designed for greater proteolytic stability and prolonged receptor engagement in experimental systems. Native amylin is a 37-residue peptide. Cagrilintide retains amylin-family pharmacology while incorporating sequence and lipid modifications that extend half-life relative to the unmodified hormone in published preclinical work.
In receptor terms, amylin analogs are typically evaluated at amylin receptors (AMY1, AMY2, AMY3), which are heterodimers of the calcitonin receptor (CTR) with receptor-activity-modifying proteins (RAMPs). That architecture makes Cagrilintide a useful probe when a lab wants to compare CTR-alone signaling with RAMP-dependent amylin-receptor complexes.
Why Amylin Analogs Appear in Metabolic Research Catalogs
Amylin signaling sits alongside incretin-family pathways in many energy-homeostasis and satiety-circuit models. Researchers often place an amylin analog next to a GLP-1 / GIP / glucagon receptor tool so they can ask how two different peptide systems look when the same cell line or assay panel is used. Cagrilintide is one of the better-documented long-acting options for that role. None of that work implies a clinical use case; it is receptor and pathway biology.
Common Laboratory Research Themes
- Amylin and calcitonin receptor binding and signaling assays (cAMP, beta-arrestin, or related readouts).
- RAMP-dependent receptor pharmacology: how AMY1/2/3 complexes differ from CTR alone.
- Comparative designs with incretin-family agonists such as GLP-3 in the same experimental panel.
- Peptide stability and formulation questions for a lipidated, long-acting amylin analog.
These are preclinical, mechanistic questions. Results in cell or animal models do not establish any effect in people.
Cagrilintide Specifications at a Glance
- Class: synthetic long-acting amylin analog
- Research focus: amylin / calcitonin receptor (AMY/CTR) signaling
- Form: lyophilized powder
- Size: 10mg vial
- Verification: HPLC purity and MS identity, third-party tested
Quality Documentation
For a modified, lipidated peptide, identity confirmation by mass spectrometry is as important as HPLC purity. Researchers should match the lot on the vial to the published Certificate of Analysis and note net peptide content versus purity percentage. See how to read a COA, net peptide content vs purity, and HPLC and mass spectrometry. Lot documentation is linked from our COA gallery, and our testing approach is described on the Quality page.
Storage and Stability
Cagrilintide is supplied lyophilized. Labs typically keep the sealed vial cold, dry, and dark, then aliquot reconstituted stock to limit freeze-thaw cycles. See lyophilized peptide handling and storage and peptide degradation pathways.
Where to Go Next
View the Cagrilintide 10mg research peptide page, or browse the Metabolic Research collection. Related guides: GLP-3 overview, 5-Amino-1MQ overview, NAD+ cellular metabolism, and the pillar Researcher's Guide to Peptides in 2026.
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting synthetic amylin analog studied as a research tool for amylin and calcitonin receptor signaling.
What receptors does Cagrilintide engage in lab models?
Published work focuses on amylin receptors (CTR/RAMP complexes) and related calcitonin-receptor pharmacology rather than incretin receptors.
How does Cagrilintide relate to GLP-3 in a research catalog?
They target different peptide systems. GLP-3 is an incretin-family triple agonist tool; Cagrilintide is an amylin analog. Labs often study them as complementary pathway probes, not substitutes.
What size is the Genetic Peptides USA vial?
Cagrilintide is supplied as a 10mg lyophilized research vial with third-party HPLC/MS documentation when available for the lot.
Is Cagrilintide for human use?
No. It is sold for laboratory research use only, not for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.
All products referenced in this article are sold strictly for laboratory research use only. They are not for human or veterinary use, are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is guidance on administration or handling outside a qualified laboratory setting.
